Kallikrein 13 Antibody (Center) Blocking peptide
€363.00
In stock
SKU
AC-BP6332a
Background:
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Expression of KLK13 is regulated by steroid hormones and may be useful as a marker for breast cancer.
Other Names:
Kallikrein-13, 3421-, Kallikrein-like protein 4, KLK-L4, KLK13, KLKL4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6332a was selected from the Center region of human KLK13. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK13
Gene ID: 26085
Primary Accession: Q9UKR3
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Expression of KLK13 is regulated by steroid hormones and may be useful as a marker for breast cancer.
Other Names:
Kallikrein-13, 3421-, Kallikrein-like protein 4, KLK-L4, KLK13, KLKL4
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6332a was selected from the Center region of human KLK13. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: KLK13
Gene ID: 26085
Primary Accession: Q9UKR3
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review